Name: Relias Media
Price range: $

Study Reveals Connection Between Condom Use and Sexual Stimuli Response

Researchers studied a population of young adult women at risk of sexually transmitted infections and HIV. They hypothesized that women with higher positive affective bias to sexual stimuli would report higher sexual risk behaviors. But the opposite proved to be true.

Study Results Highlight Challenge of Ruling out Pregnancy During Contraceptive Counseling

The recommended ways of ruling out patient pregnancy before starting a new contraceptive include a pregnancy test, the date of the patient’s last unprotected sexual intercourse, and the patient’s symptoms. But there often are cases where it is difficult to rule out pregnancy.

Model Contraceptive Program Increased LARC Access Among Title X Clients

The Affordable Care Act’s contraceptive mandate led to an increase in injectable contraceptives, but did not help improve access to long-acting, reversible contraceptives, research revealed.

Family Planning Centers Looking for Solutions in a Difficult Era

In recent years, family planning clinics have faced many obstacles to providing contraceptive access to all patients who need it. Access issues worsened under changes to Title X and the Supreme Court’s recent ruling that allows some employers to opt out of providing contraception coverage. Reproductive health experts worry these recent changes — and COVID-19’s effect on access — could result in more unintended pregnancies.

Supreme Court’s Contraception Ruling Could Affect Women Nationwide

The Affordable Care Act mandated that employers provide contraceptive coverage to workers at no cost. In July, the U.S. Supreme Court allowed a Trump administration regulation to let employers with religious or moral objections opt out of the mandate.

Updated Guidelines for HPV Vaccine

Recommendations call for providing vaccine to boys and girls starting at age 9 years.

We’d Love to Hear from You!

Please complete our annual reader survey (https://bit.ly/2XYHWdM).

Malaria Prophylaxis During Pregnancy

In a retrospective study of American military women involving 50 treated with atovaquone-proguanil and 156 exposed to mefloquine, no increase in risk of fetal loss or adverse infant outcomes was identified. Atovaquone-proguanil seems safe for use in pregnancy, but data are limited.